Lannett Faces Shareholder Suit Over Price-Fixing Scheme
A shareholder on Wednesday filed a securities class action against generic-drug maker Lannett Company Inc. in a Pennsylvania federal court, saying Lannett's executives hid a scheme to fix the prices of...To view the full article, register now.
Already a subscriber? Click here to view full article